2V125 (Orkambi ivacaftor 125 mg / lumacaftor 200 mg)
Generic Name: ivacaftor/lumacaftor
Pill imprint 2V125 has been identified as Orkambi ivacaftor 125 mg / lumacaftor 200 mg.
Orkambi is used in the treatment of cystic fibrosis and belongs to the drug class CFTR combinations. There is no proven risk in humans during pregnancy. Orkambi ivacaftor 125 mg / lumacaftor 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ivacaftor 125 mg / lumacaftor 200 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- CFTR combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Vertex Pharmaceuticals Incorporated
More about Orkambi (ivacaftor / lumacaftor)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.